Literature DB >> 28191644

NK-cell receptors NKp46 and NCR1 control human metapneumovirus infection.

Mohammad Diab1, Ariella Glasner1, Batya Isaacson1, Yotam Bar-On1, Yaron Drori2,3, Rachel Yamin1, Alexandra Duev-Cohen1, Oded Danziger4, Rachel Zamostiano4, Michal Mandelboim2,3, Stipan Jonjic5,6, Eran Bacharach4, Ofer Mandelboim1.   

Abstract

Natural killer (NK) cells are capable of killing various pathogens upon stimulation of activating receptors. Human metapneumovirus (HMPV) is a respiratory virus, which was discovered in 2001 and is responsible for acute respiratory tract infection in infants and children worldwide. HMPV infection is very common, infecting around 70% of all children under the age of five. Under immune suppressive conditions, HMPV infection can be fatal. Not much is known on how NK cells respond to HMPV. In this study, using reporter assays and NK-cell cytotoxicity assays performed with human and mouse NK cells, we demonstrated that the NKp46-activating receptor and its mouse orthologue Ncr1, both members of the natural cytotoxicity receptor (NCR) family, recognized an unknown ligand expressed by HMPV-infected human cells. We demonstrated that MHC class I is upregulated and MICA is downregulated upon HMPV infection. We also characterized mouse NK-cell phenotype in the blood and the lungs of HMPV-infected mice and found that lung NK cells are more activated and expressing NKG2D, CD43, CD27, KLRG1, and CD69 compared to blood NK cells regardless of HMPV infection. Finally, we demonstrated, using Ncr1-deficient mice, that NCR1 plays a critical role in controlling HMPV infection.
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  HMPV; MHC class I; MICA; NCR1; NCRs; NK cells; NKG2D; NKp46; respiratory infection

Mesh:

Substances:

Year:  2017        PMID: 28191644     DOI: 10.1002/eji.201646756

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

Review 1.  Mutually assured destruction: the cold war between viruses and natural killer cells.

Authors:  Ayad Ali; Ivayla E Gyurova; Stephen N Waggoner
Journal:  Curr Opin Virol       Date:  2019-03-13       Impact factor: 7.090

2.  Zika Virus Escapes NK Cell Detection by Upregulating Major Histocompatibility Complex Class I Molecules.

Authors:  Ariella Glasner; Esther Oiknine-Djian; Yiska Weisblum; Mohammad Diab; Amos Panet; Dana G Wolf; Ofer Mandelboim
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

Review 3.  The Natural Cytotoxicity Receptors in Health and Disease.

Authors:  Alexander David Barrow; Claudia Jane Martin; Marco Colonna
Journal:  Front Immunol       Date:  2019-05-07       Impact factor: 7.561

Review 4.  Cell-Mediated Responses to Human Metapneumovirus Infection.

Authors:  Marlies Ballegeer; Xavier Saelens
Journal:  Viruses       Date:  2020-05-14       Impact factor: 5.048

5.  Increased NK cell immunity in a transgenic mouse model of NKp46 overexpression.

Authors:  Ariella Glasner; Batya Isaacson; Sergey Viukov; Tzahi Neuman; Nehemya Friedman; Michal Mandelboim; Veronika Sexl; Jacob H Hanna; Ofer Mandelboim
Journal:  Sci Rep       Date:  2017-10-12       Impact factor: 4.379

Review 6.  Innate Immune Components that Regulate the Pathogenesis and Resolution of hRSV and hMPV Infections.

Authors:  Catalina A Andrade; Gaspar A Pacheco; Nicolas M S Gálvez; Jorge A Soto; Susan M Bueno; Alexis M Kalergis
Journal:  Viruses       Date:  2020-06-12       Impact factor: 5.048

7.  Human Metapneumovirus Escapes NK Cell Recognition through the Downregulation of Stress-Induced Ligands for NKG2D.

Authors:  Mohammad Diab; Dominik Schmiedel; Einat Seidel; Eran Bacharach; Ofer Mandelboim
Journal:  Viruses       Date:  2020-07-20       Impact factor: 5.048

Review 8.  Innate immune responses in RNA viral infection.

Authors:  Qian Xu; Yuting Tang; Gang Huang
Journal:  Front Med       Date:  2020-12-01       Impact factor: 9.927

9.  Fingolimod Therapy in Multiple Sclerosis Leads to the Enrichment of a Subpopulation of Aged NK Cells.

Authors:  Jan Dörr; Carmen Infante-Duarte; Svenja C Schwichtenberg; Anne Wisgalla; Maria Schroeder-Castagno; Cesar Alvarez-González; Stephan Schlickeiser; Nadja Siebert; Judith Bellmann-Strobl; Klaus-Dieter Wernecke; Friedemann Paul
Journal:  Neurotherapeutics       Date:  2021-07-09       Impact factor: 7.620

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.